CY1107242T1 - Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης - Google Patents

Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης

Info

Publication number
CY1107242T1
CY1107242T1 CY20081100293T CY081100293T CY1107242T1 CY 1107242 T1 CY1107242 T1 CY 1107242T1 CY 20081100293 T CY20081100293 T CY 20081100293T CY 081100293 T CY081100293 T CY 081100293T CY 1107242 T1 CY1107242 T1 CY 1107242T1
Authority
CY
Cyprus
Prior art keywords
eczema
treatment
pulmony
sports
oxygen
Prior art date
Application number
CY20081100293T
Other languages
English (en)
Inventor
Timothy David Meakin
Craig Leonard Heatley
Dianne Cadwallader
Original Assignee
Meracol Corporation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ50452500A external-priority patent/NZ504525A/xx
Application filed by Meracol Corporation Limited filed Critical Meracol Corporation Limited
Publication of CY1107242T1 publication Critical patent/CY1107242T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Στην παρούσα περιγράφεται η θεραπευτική αγωγή ανθρώπων ή άλλων θηλαστικών όσον αφορά το έκζεμα ή/και την ψωρίαση με τη χρησιμοποίηση δοσολογικών μορφών ή συνθέσεων που περιλαμβάνουν μυριστικό κητύλιο μεμονωμένα ή (σε πρόσμιξη ή κατ’ αλληλουχία) αμφότερα μυριστικό κητύλιο και παλμιτικό κητύλιο.
CY20081100293T 2000-05-12 2008-03-17 Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης CY1107242T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ50452500A NZ504525A (en) 2000-05-12 2000-05-12 Use of cetyl alcohol esters of myristic and palmitic acids to treat eczema and psoriasis
NZ50722800 2000-09-28
EP01934672A EP1335719B1 (en) 2000-05-12 2001-05-11 Cetyl myristate and cetyl palmitate for treating eczema and/or psoriasis

Publications (1)

Publication Number Publication Date
CY1107242T1 true CY1107242T1 (el) 2012-11-21

Family

ID=26652173

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100293T CY1107242T1 (el) 2000-05-12 2008-03-17 Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης

Country Status (8)

Country Link
EP (1) EP1335719B1 (el)
AT (1) ATE381327T1 (el)
AU (2) AU6083301A (el)
CA (1) CA2408541C (el)
CY (1) CY1107242T1 (el)
DE (1) DE60132008T2 (el)
ES (1) ES2298237T3 (el)
WO (1) WO2001085163A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2001085162A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating irritable bowel syndrome or disease
NZ533370A (en) 2004-06-03 2006-11-30 Meracol Corp Ltd Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis
EP2149375A1 (en) 2008-07-28 2010-02-03 Despharma Kft. Compositions for the treatment of dermatological diseases, and uses thereof
EP2441445A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2441441A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi A sieving method for cetyl myristate and/or cetyl palmitate
EP2441444A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
EP2441446A1 (en) 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations
EP2471386A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471385A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471528A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi A preparation method for suspension of cetyl myristate and/or cetyl palmitate
EP2471387A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471384A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Suspension formulations of cetyl myristate and/or cetyl palmitate
EP2471514A1 (en) 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Controlled moisture content of cetyl myristate and/or cetyl palmitate granules or formulations
EP2526936B1 (en) 2011-05-23 2015-04-15 Deva Holding Anonim Sirketi Particle size distribution of cetyl myristate and/or cetyl palmitate
EP2526931B1 (en) 2011-05-23 2014-12-17 Deva Holding Anonim Sirketi Wet granulation methods of cetyl myristate and/or cetyl palmitate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
DE4308282C2 (de) * 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
US5886038A (en) * 1998-03-24 1999-03-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
US6841539B1 (en) * 1998-05-21 2005-01-11 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
GB9810949D0 (en) * 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AU4917900A (en) * 1999-05-07 2000-11-21 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
WO2001085162A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating irritable bowel syndrome or disease

Also Published As

Publication number Publication date
CA2408541A1 (en) 2001-11-15
CA2408541C (en) 2009-07-28
AU2001260833B2 (en) 2005-09-29
AU6083301A (en) 2001-11-20
DE60132008T2 (de) 2008-12-11
EP1335719A1 (en) 2003-08-20
EP1335719B1 (en) 2007-12-19
ES2298237T3 (es) 2008-05-16
WO2001085163A1 (en) 2001-11-15
DE60132008D1 (de) 2008-01-31
EP1335719A4 (en) 2004-02-25
ATE381327T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
CY1107242T1 (el) Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης
CY1107615T1 (el) Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY1106816T1 (el) 1,5-δισυποκαταστημενες ενωσεις 3,4-διυδρο-1h-πυριμιδο [4,5-d] πυριμιδιν-2-ονης και η χρησιμοποιηση αυτων δια τη θεραπευτικη αγωγη ασθενειων εις τις οποιες μεσολαβει η csbp/p38 κιναση
CY1114133T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ
CY2014031I1 (el) Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae
CY1108874T1 (el) ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ
DE59709437D1 (de) Neue phenanthridine
ATE232396T1 (de) Oxydiertes thymosin beta 4
CY1107424T1 (el) Χρηση ενος αναστολεα ibat για τη θεραπευτικη αντιμετωπιση η προφυλαξη απο δυσκοιλιοτητα
GB0025173D0 (en) Therapeutic agents
CY1108563T1 (el) Μεθοδοι και υλικα για τη θεραπεια της ανεπαρκειας (ελλειψης) τεστοστερονης στους ανδρες
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
DE60132444D1 (de) Behandlung von reizkolon-syndrom oder -krankheit
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
DE60116359D1 (de) Kahalalid f formulierung
DE60112756D1 (de) Racecadotril enthaltende trockene pulverformulierung
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
UY26498A1 (es) Pirroles sustituidos
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
NO20005548L (no) Mykobakterieinhibitorer
BR0015121A (pt) Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação